Contraception

“But researchers did introduce racial bias by overwhelmingly apportioning the potential health risks of experimental birth control technologies to women of color, including black American women. The Pill, Norplant, and the Depo-Provera shot were first tested in Mexico, Africa, Brazil, Puerto Rico, and India. Once approved, they were administered to large number of girls and women in U.S. venues that are disproportionately and, usually, overwhelmingly African American and Hispanic. . . . . they were unwittingly participants in a research study. . . . reproductive drug testing makes poor women of color, at home and abroad, bear the brunt of any health risks that emerge” (Montgomery, 279-80).